Reader Remarks on:

DIRA: A New Autoinflammatory Disease

DIRA: A New Autoinflammatory Disease

DIRA: A New Autoinflammatory Disease

Hartmut Michels, 13 Jun 2009 7:00 AM EST

Competing interests: None declared

The destription of DIRA including its feature "sterile multifocal osteomyelitis" and its successful treatment with anakinra might lead to applying anakinra or other IL-1 inhibiting substances also to treatment- resistant cases of "chronic recurrent multifocal osteomyelitis" (CRMO).

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Remark subject:*

Your remark:*

Fields marked with an * are required.

Name as you'd like it to appear:
First & middle initial:*

Last:*

Email address (will not
be published):*

Professional specialty:*

Place of work (optional):

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

No competing interests

Or, the following competing interests (for example, financial stakes or professional relationships):

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?